Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Academic Entrepreneur—An Oxymoron?

Academic Entrepreneur—An Oxymoron? Academic Entrepreneur—An Oxymoron? — MI var callbackToken='4736BC5616AFFE8'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve User Name Password Sign In Academic Entrepreneur—An Oxymoron? Kelvin Gee , Ph.D. , Professor of Pharmacology at UC Irvine E-mail kwgee@uci.edu ; fax (949) 824-345 Among many academics in the biomedical sciences, there is a fair amount of lore, mystique, and generally fuzzy notions about the prospect of initiating a biotech or biopharmaceutical company. And although there is no scarcity of general business advice—especially from organizations where, for the price of admission or annual dues, people with business ideas are thrown into a room with investors over wine and cheese to see if “something useful” happens—very little information specifically addresses the biomedical researcher with entrepreneurial ambitions. For inspiration, you might consult the few books that deal with the history of successful biotech companies ( 1 ), but where do you turn for help when you want to commercialize your ideas—or, as my traditional academic colleagues have expressed it, when you desire to pursue “the dark side of the force”? Here, I would like to provide a thumbnail sketch, from an academic perspective, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular Interventions Am. Soc for Pharma & Experimental Therapeutics

Academic Entrepreneur—An Oxymoron?

Molecular Interventions , Volume 1 (4): 186 – Oct 1, 2001

Academic Entrepreneur—An Oxymoron?

Molecular Interventions , Volume 1 (4): 186 – Oct 1, 2001

Abstract

Academic Entrepreneur—An Oxymoron? — MI var callbackToken='4736BC5616AFFE8'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve User Name Password Sign In Academic Entrepreneur—An Oxymoron? Kelvin Gee , Ph.D. , Professor of Pharmacology at UC Irvine E-mail kwgee@uci.edu ; fax (949) 824-345 Among many academics in the biomedical sciences, there is a fair amount of lore, mystique, and generally fuzzy notions about the prospect of initiating a biotech or biopharmaceutical company. And although there is no scarcity of general business advice—especially from organizations where, for the price of admission or annual dues, people with business ideas are thrown into a room with investors over wine and cheese to see if “something useful” happens—very little information specifically addresses the biomedical researcher with entrepreneurial ambitions. For inspiration, you might consult the few books that deal with the history of successful biotech companies ( 1 ), but where do you turn for help when you want to commercialize your ideas—or, as my traditional academic colleagues have expressed it, when you desire to pursue “the dark side of the force”? Here, I would like to provide a thumbnail sketch, from an academic perspective,

Loading next page...
 
/lp/am-soc-for-pharma-experimental-therapeutics/academic-entrepreneur-an-oxymoron-lKlN81cFlO

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Am. Soc for Pharma & Experimental Therapeutics
Copyright
Copyright © Molecular Interventions
ISSN
1534-0384
eISSN
1543-2548
Publisher site

Abstract

Academic Entrepreneur—An Oxymoron? — MI var callbackToken='4736BC5616AFFE8'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve User Name Password Sign In Academic Entrepreneur—An Oxymoron? Kelvin Gee , Ph.D. , Professor of Pharmacology at UC Irvine E-mail kwgee@uci.edu ; fax (949) 824-345 Among many academics in the biomedical sciences, there is a fair amount of lore, mystique, and generally fuzzy notions about the prospect of initiating a biotech or biopharmaceutical company. And although there is no scarcity of general business advice—especially from organizations where, for the price of admission or annual dues, people with business ideas are thrown into a room with investors over wine and cheese to see if “something useful” happens—very little information specifically addresses the biomedical researcher with entrepreneurial ambitions. For inspiration, you might consult the few books that deal with the history of successful biotech companies ( 1 ), but where do you turn for help when you want to commercialize your ideas—or, as my traditional academic colleagues have expressed it, when you desire to pursue “the dark side of the force”? Here, I would like to provide a thumbnail sketch, from an academic perspective,

Journal

Molecular InterventionsAm. Soc for Pharma & Experimental Therapeutics

Published: Oct 1, 2001

There are no references for this article.